Theraclion SA
Theraclion SA provides therapeutic ultrasound equipment. It offers SONOVEIN, a robotic solution for the non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for the echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installed on the device before treatment to protect the patient's skin and optimize imag… Read more
Theraclion SA - Asset Resilience Ratio
Theraclion SA (TCLIF) has an Asset Resilience Ratio of 13.46% as of June 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2010–2022)
This chart shows how Theraclion SA's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Theraclion SA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $2.00 Million | 13.46% |
| Total Liquid Assets | $2.00 Million | 13.46% |
Asset Resilience Insights
- Moderate Liquidity: Theraclion SA has 13.46% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
Theraclion SA Industry Peers by Asset Resilience Ratio
Compare Theraclion SA's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022 |
Medical Devices | 0.01% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.26% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 7.79% |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932 |
Medical Devices | 6.64% |
|
Shinhung
KO:004080 |
Medical Devices | 4.17% |
|
UMediC Group Berhad
KLSE:0256 |
Medical Devices | 1.48% |
|
Osang Healthcare Co.,Ltd
KQ:036220 |
Medical Devices | 9.34% |
|
HansBiomed Corporation
KQ:042520 |
Medical Devices | 9.13% |
Annual Asset Resilience Ratio for Theraclion SA (2010–2022)
The table below shows the annual Asset Resilience Ratio data for Theraclion SA.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2022-12-31 | 0.22% | $31.10K | $13.94 Million | -0.04pp |
| 2021-12-31 | 0.26% | $31.10K | $11.83 Million | -0.03pp |
| 2020-12-31 | 0.29% | $31.10K | $10.55 Million | 0.00pp |
| 2019-12-31 | 0.30% | $31.10K | $10.51 Million | -0.03pp |
| 2018-12-31 | 0.33% | $31.10K | $9.56 Million | +0.10pp |
| 2017-12-31 | 0.23% | $31.10K | $13.77 Million | -33.97pp |
| 2016-12-31 | 34.19% | $5.03 Million | $14.71 Million | +14.41pp |
| 2015-12-31 | 19.78% | $1.83 Million | $9.26 Million | +1.29pp |
| 2014-12-31 | 18.50% | $1.53 Million | $8.28 Million | +17.44pp |
| 2013-12-31 | 1.06% | $31.10K | $2.94 Million | +0.08pp |
| 2012-12-31 | 0.97% | $31.10K | $3.20 Million | -23.96pp |
| 2011-12-31 | 24.93% | $575.16K | $2.31 Million | +24.66pp |
| 2010-12-31 | 0.27% | $10.60K | $3.91 Million | -- |